Mondelli M U, Bortolotti F, Pontisso P, Rondanelli E G, Williams R, Realdi G, Alberti A, Eddleston A L
Istituto di Clinica delle Malattie Infettive, Università di Pavia, IRCCS Policlinico S. Matteo, Italy.
Clin Exp Immunol. 1987 May;68(2):242-50.
We have investigated the specificity of cell-mediated cytotoxicity for autologous liver cells in 10 patients with acute hepatitis B in relation to the expression of hepatitis B virus (HBV) antigens and IgG on the surface of hepatocytes. Hepatitis B core antigen (HBcAg) was expressed on hepatocytes from six patients and hepatitis B surface antigen (HBcAG) from four, though always in association with HBcAg. Peripheral blood mononuclear cells (PBMC) were significantly cytotoxic in eight of the patients, and fractionation experiments revealed that the cytotoxic effect was equally mediated by T and non-T cells. Monoclonal antibody blocking experiments showed that HBcAg was the major target antigen recognized by T cells, although some inhibition of cytotoxicity was observed after pretreatment of target cells with monoclonal anti-HBs in patients with liver cell surface HBsAg. In contrast, non-T cells were not consistently inhibited by either monoclonal anti-HBc or anti-HBs. These findings further suggest that the HBV nucleoprotein serves as a target for recognition by cytotoxic T cells.
我们研究了10例急性乙型肝炎患者中细胞介导的对自体肝细胞细胞毒性的特异性,该特异性与乙型肝炎病毒(HBV)抗原及IgG在肝细胞表面的表达有关。6例患者的肝细胞表达乙型肝炎核心抗原(HBcAg),4例表达乙型肝炎表面抗原(HBsAg),且HBsAg总是与HBcAg共同表达。8例患者的外周血单个核细胞(PBMC)具有显著的细胞毒性,分级实验表明细胞毒性效应由T细胞和非T细胞共同介导。单克隆抗体阻断实验表明,HBcAg是T细胞识别的主要靶抗原,尽管在肝细胞表面有HBsAg的患者中,用抗HBs单克隆抗体预处理靶细胞后观察到细胞毒性有一定程度的抑制。相比之下,抗HBc或抗HBs单克隆抗体对非T细胞的抑制作用并不一致。这些发现进一步表明,HBV核蛋白是细胞毒性T细胞识别的靶标。